Liver disease as risk factor for cystic fibrosis-related diabetes development

Acta Paediatrica, International Journal of Paediatrics

Volumn 96, Issue 5, 2007, Pages 736-739

  Minicucci, L ^a   Lorini, R ^a   Giannattasio, A ^a   Colombo, C ^b   Iapichino, L ^c,d   Reali, M F ^e   Padoan, R ^f   Calevo, M G ^g   Casciaro, R ^a   De Alessandri, A ^a   Haupt, R ^g  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c Di Cristina Hospital   (Italy)

^d UNIVERSITY OF PALERMO   (Italy)

^e UNIVERSITY OF FLORENCE   (Italy)

^f Ospedali Civili   (Italy)

^g G GASLINI INSTITUTE   (Italy)

Author keywords

Cystic fibrosis; Diabetes mellitus; Liver disease

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CASE CONTROL STUDY; COMPARATIVE STUDY; CONTROLLED STUDY; CYSTIC FIBROSIS; DATA ANALYSIS; DIABETES MELLITUS; DISEASE SEVERITY; EVALUATION; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC RISK; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIVER DISEASE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; PANCREAS EXOCRINE INSUFFICIENCY; PRIORITY JOURNAL; PROBABILITY; RISK FACTOR;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; COMORBIDITY; CYSTIC FIBROSIS; DIABETES MELLITUS; HUMANS; LIVER DISEASES; RISK FACTORS;

EID: 34247543025     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2007.00250.x     Document Type: Article

References (29)

1. Moran A, Doberty L, Wang X, Thomas W. Abnormal glucose metabolism in cystic fibrosis. J Pediatr 1998 133 : 10 7.
2. Milla CE, Warwick WJ, Moran A. Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline. Am J Respir Crit Care Med 2000 162 : 891 95.
3. Dobson L, Hattersley AT, Tiley S, Elworthy S, Oades P, Sheldon C. Clinical improvement in cystic fibrosis with early insulin treatment. Arch Dis Child 2002 87 : 430 1.
4. Lanng S. Glucose intolerance in cystic fibrosis patients. Paediatr Respir Rev 2001 2 : 253 2599.
5. Mueller-Brandes C, Holl R W, Nastoli M, Ballmann M. New criteria for impaired fasting glucose and screening for diabetes in cystic fibrosis. Eur Respir J 2005 25 : 715 7.
6. Moran A, Hardin D, Rodman D, Allen HF, Beall RJ, Borowitz D, et al. Diagnosis, screening and management of Cystic Fibrosis Related Diabetes mellitus. A consensus conference report. Diabetes Res Clin Pract 1999 45 : 61 73.
7. Mackie A, Thornton S, Edenborough F. Cystic Fibrosis-related diabetes. Diabetic Med 2003 20 : 425 36.
8. Marshall BC, Butler SM, Stoddard M, Moran AM, Liou TG, Morgan WJ. Epidemiology of cystic fibrosis-related diabetes. J Pediatr 2005 146 : 681 7.
9. Del Vecchio Blanco C, Gentile S, Marmo R, Carbone L, Coltori M. Alterations of glucose metabolism in chronic liver disease. Diabetes Res Clin Pract 1990 8 : 29 36.
10. Narkewicz MR. Markers of Cystic Fibrosis - associated liver disease. J Pediatr Gastroenterol Nutr 2001 32 : 421 2.
11. Kock C, Lanng S. Other organ systems. Diabetes Mellitus. In : Hodson ME, Geddes DM, editors. Cystic fibrosis. 2nd ed. London : Arnold, 2000.
12. Lombardo F, De Luca F, Rosano M, Sferlazzas C, Lucanto C, Arrigo T, et al. Natural history of glucose tolerance, beta-cell function and peripheral insulin sensitivity in cystic fibrosis patients with fasting euglycemia. Eur J Endocrinol 2003 149 : 53 9.
13. Hardin DS, Moran A. Diabetes Mellitus in Cystic Fibrosis. Endocrinol Metab Clin North Am 1999 28 : 787 800.
14. Kock C, Cuppens H, Rainisio M, Madessani U, Harms HK, Hodson ME, et al. European Epidemiologic Registry of Cystic Fibrosis (ERCF). Comparison of major disease manifestations between patients with different classes of mutations. Pediatr Pulmonol 2001 31 : 1 2.
15. Lanng S, Thorsteinsson B, Nerup J, Koch C. Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis. Eur J Pediatr 1992 151 : 684 7.
16. Castro FA, Fernandes MI, Junior RM, Foss MC. On the frequency of diabetes mellitus and glucose intolerance in patients with cystic fibrosis. J Pediatr (RioJ) 2001 77 : 321 6.
17. Moran A. Diagnosis, screening and management of cystic fibrosis-related diabetes. Curr Diab Rep 2002 2 : 111 5.
18. Solomon M, Wilson D, Corey M, Kalnins D, Zielensky J, Tsui L, et al. Glucose intolerance in children with cystic fibrosis. J Pediatr 2003 142 : 128 32.
19. Corbett K, Kelleher S, Rowland M, Daly L, Drumm B, Canny G, et al. Cystic Fibrosis-associated liver disease: a population-based study. J Pediatr 2004 145 : 327 32.
20. Colombo C, Battezzati P, Crosignani A, Morabito A, Costantini D, Padoan R, et al. Liver disease in cystic fibrosis: a prospective study on incidence, risk factors and outcome. Hepatology 2002 36 : 1374 82.
21. Debray D, Lykavieris P, Gauthier F, Dousset B, Sardet A, Munck A, et al. Outcome of cystic fibrosis-associated liver cirrhosis: management of portal hypertension. J Hepatol 1999 31 : 77 83.
22. Westaby D. Liver and biliary disease in cystic fibrosis. In : Hodson ME, Geddes DM, editors. Cystic fibrosis, 2nd ed. London : Arnold, 2000.
23. Diwakar V, Pearson L, Beath S. Liver disease in children with cystic fibrosis. Paediatric Respir Rev 2001 2 : 340 9.
24. Wilschanski M, Rivlin J, Cohen S, Augarten A, Blau H, Aviram M, et al. Clinical and genetic risk factors for cystic fibrosis-related liver disease. Pediatrics 1999 103 : 52 7.
25. Holstein A, Hinze S, Thiessen E, Plaschke A, Egberts EH. Clinical implications of hepatogenous diabetes in liver cirrhosis. J Gastroenterol Hepatol 2002 17 : 677 81.
26. Hardin DS, Leblanc A, Marshall G, Seilheimer DK. Mechanism of insulin resistance in cystic fibrosis. Am J Physiol Endocrinol Metab 2001 281 : E1022 8.
27. Holl RW, Heinze E, Wolf A, Rank M, Teller WM. Reduced pancreatic insulin release and reduced peripheral insulin sensitivity contribute to hyperglycaemia in cystic fibrosis. Eur J Pediatr 1995 154 : 356 61.
28. Hardin DS, LeBlanc A, Para L, Seilheimer DK. Hepatic insulin resistance and defects in substrate utilization in Cystic Fibrosis. Diabetes 1999 48 : 1082 7.
29. Dobson L, Sheldon CD, Hattersley AT. Conventional measures underestimate glycaemia in cystic fibrosis patients. Diabet Med 2004 21 : 691 6.